Furthermore, metformin was shown to upregulate liver mitochondrial GNMT protein expression in an apolipoprotein E knockout (apoE−/−) NAFLD mouse model [19]. This evidence concerns the gene APOE and metabolic dysfunction-associated steatotic liver disease.